SCHEMBL17875898

SCHEMBL17875898

c1cncc(-c2cc(-c3cccnc3)cc(-c3ccc4c(c3)-c3cc(-c5ccc6c(c5)oc5ccccc56)ccc3COC4)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 11/20 0.41
CYP11B2 P19099 10/20 0.41
CYP19A1 P11511 3/20 0.41
TDP2 O95551 2/20 0.40
MAPT P10636 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HSD17B10 Q99714 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
HPGD P15428 1/20 0.40
RAB9A P51151 1/20 0.40
PGR P06401 1/20 0.39
CYP1A2 P05177 4/20 0.38
CYP17A1 P05093 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
PIM1 P11309 1/20 0.36
PIM2 Q9P1W9 1/20 0.36
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875864 0.96 CYP11B1 (0.41) CYP11B1CYP11B2CYP19A1TDP2MAPT
SCHEMBL17875835 0.96 CYP11B1 (0.41) CYP11B1CYP11B2CYP19A1TDP2MAPT
SCHEMBL17875902 0.93 CYP11B1 (0.41) CYP11B1CYP11B2CYP19A1TDP2MAPT
SCHEMBL17875849 0.89 CYP11B1 (0.41) CYP11B1CYP11B2CYP19A1TDP2PGR
SCHEMBL17875865 0.89 CYP11B1 (0.41) CYP11B1CYP11B2CYP19A1TDP2PGR
SCHEMBL17875903 0.88 CYP11B1 (0.39) CYP11B1CYP11B2CYP19A1TDP2MAPT
SCHEMBL17875781 0.88 CYP11B1 (0.40) CYP11B1CYP11B2CYP19A1TDP2MAPT
SCHEMBL17875892 0.87 ALOX5 (0.46) CYP11B1CYP11B2CYP19A1TDP2PGR
SCHEMBL17875896 0.87 NPC1 (0.41) CYP19A1MAPTALDH1A1KDM4ENPC1
SCHEMBL17875997 0.86 CYP19A1 (0.41) CYP11B1CYP11B2CYP19A1TDP2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 CYP11B1 938/4885CYP11B2 1374/4885CYP19A1 167/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP11B1 938/4885CYP11B2 1374/4885CYP19A1 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.